Your browser doesn't support javascript.
loading
Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study.
Sangroongruangsri, Sermsiri; Chaikledkaew, Usa; Kumluang, Suthasinee; Wu, Olivia; Geue, Claudia; Ratanapakorn, Tanapat; Leelahavarong, Pattara; Ingsrisawang, Lily; Ruamviboonsuk, Paisan; Taweebanjongsin, Wongsiri; Choovuthayakorn, Janejit; Singalavanija, Apichart; Hanutsaha, Prut; Kulvichit, Kittisak; Ratanapojnard, Thitiporn; Wongsawad, Warapat; Teerawattananon, Yot.
Afiliação
  • Sangroongruangsri S; Social and Administrative Pharmacy Excellence Research (SAPER) Unit, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, 447 Sri-Ayuthaya Road, Rajathevi, Bangkok, 10400, Thailand.
  • Chaikledkaew U; Social and Administrative Pharmacy Excellence Research (SAPER) Unit, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, 447 Sri-Ayuthaya Road, Rajathevi, Bangkok, 10400, Thailand. usa.chi@mahidol.ac.th.
  • Kumluang S; Health Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thailand.
  • Wu O; Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
  • Geue C; Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
  • Ratanapakorn T; Department of Ophthalmology, Khon Kaen University, Khon Kaen, Thailand.
  • Leelahavarong P; Health Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thailand.
  • Ingsrisawang L; Department of Statistics, Faculty of Science, Kasetsart University, Bangkok, Thailand.
  • Ruamviboonsuk P; Department of Ophthalmology, Faculty of Medicine, Rajavithi Hospital, Rangsit University, Bangkok, Thailand.
  • Taweebanjongsin W; Mettapracharak Eye Institute, Mettapracharak (Wat Rai Khing) Hospital, Nakhon Pathom, Thailand.
  • Choovuthayakorn J; Department of Ophthalmology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Singalavanija A; Department of Ophthalmology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Hanutsaha P; Department of Ophthalmology, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
  • Kulvichit K; Department of Ophthalmology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Ratanapojnard T; Department of Ophthalmology, Phramongkutklao Hospital, Phramongkutklao College of Medicine, Bangkok, Thailand.
  • Wongsawad W; Mettapracharak Eye Institute, Mettapracharak (Wat Rai Khing) Hospital, Nakhon Pathom, Thailand.
  • Teerawattananon Y; Health Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thailand.
Clin Drug Investig ; 38(9): 853-865, 2018 Sep.
Article em En | MEDLINE | ID: mdl-30069864
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Retinianas / Inibidores da Angiogênese / Bevacizumab / Ranibizumab Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Retinianas / Inibidores da Angiogênese / Bevacizumab / Ranibizumab Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2018 Tipo de documento: Article